Anastasaki M, Papadakis S, Gergianaki I, Papastamatiou L, Aligizakis E, Grillaki N
Front Med (Lausanne). 2024; 11:1383112.
PMID: 39640981
PMC: 11617198.
DOI: 10.3389/fmed.2024.1383112.
Heyens L, Kenjic H, Dagnelie P, Schalkwijk C, Stehouwer C, Meex S
BMJ Open Gastroenterol. 2024; 11(1).
PMID: 39615896
PMC: 11624825.
DOI: 10.1136/bmjgast-2024-001466.
Soluyanova P, Quintas G, Perez-Rubio A, Rienda I, Moro E, van Herwijnen M
Biomolecules. 2024; 14(11).
PMID: 39595599
PMC: 11592063.
DOI: 10.3390/biom14111423.
Ni J, Huang Y, Xiang Q, Zheng Q, Xu X, Qin Z
Interact J Med Res. 2024; 13:e56035.
PMID: 39172506
PMC: 11377904.
DOI: 10.2196/56035.
Mantovani A, Morandin R, Fiorio V, Lando M, Petta S, Ferraro P
Intern Emerg Med. 2024; 19(6):1745-1755.
PMID: 38992323
PMC: 11405432.
DOI: 10.1007/s11739-024-03705-5.
The Role of _rs738409 Gene Variant, Lifestyle Factors, and Bioactive Compounds in Nonalcoholic Fatty Liver Disease: A Population-Based and Molecular Approach towards Healthy Nutrition.
Liu M, Park S
Nutrients. 2024; 16(8).
PMID: 38674929
PMC: 11054963.
DOI: 10.3390/nu16081239.
Association between metabolic dysfunction-associated steatotic liver disease and risk of incident pancreatic cancer: a systematic review and meta-analysis of cohort studies.
Zhang Y, Zhou B, Zhan J, Du B
Front Oncol. 2024; 14:1366195.
PMID: 38567158
PMC: 10985331.
DOI: 10.3389/fonc.2024.1366195.
Diagnostic accuracy and clinical impact of MRI-based technologies for patients with non-alcoholic fatty liver disease: systematic review and economic evaluation.
Bresnahan R, Duarte R, Mahon J, Beale S, Chaplin M, Bhattacharyya D
Health Technol Assess. 2023; 27(10):1-115.
PMID: 37839810
PMC: 10591209.
DOI: 10.3310/KGJU3398.
Hepatic steatosis with significant fibrosis is associated with an increased 10-year estimated risk of cardiovascular disease in adults with type 1 diabetes mellitus.
Mantovani A, Morieri M, Palmisano L, Masulli M, Cossu E, Baroni M
Cardiovasc Diabetol. 2023; 22(1):204.
PMID: 37563618
PMC: 10416459.
DOI: 10.1186/s12933-023-01945-x.
A systematic review and meta-analysis of cohort studies on the potential association between NAFLD/MAFLD and risk of incident atrial fibrillation.
Zhou B, Ju S, Mei Y, Jiang X, Wang M, Zheng A
Front Endocrinol (Lausanne). 2023; 14:1160532.
PMID: 37476492
PMC: 10355839.
DOI: 10.3389/fendo.2023.1160532.
Non-alcoholic fatty liver disease in pregnancy.
Benson C, Cobbold J, Frise C
Obstet Med. 2023; 16(2):116-119.
PMID: 37441657
PMC: 10334038.
DOI: 10.1177/1753495X211034709.
Performance of the Enhanced Liver Fibrosis Score, Comparison with Vibration-controlled Transient Elastography Data, and Development of a Simple Algorithm to Predict Significant Liver Fibrosis in a Community-based Liver Service: A Retrospective....
Reinson T, Patel J, Mathews M, Fountain D, Buchanan R, Byrne C
J Clin Transl Hepatol. 2023; 11(4):800-808.
PMID: 37408822
PMC: 10318295.
DOI: 10.14218/JCTH.2022.00335.
Non-Alcoholic Fatty Liver Disease as an Emerging Risk Factor for Heart Failure.
Inciardi R, Mantovani A, Targher G
Curr Heart Fail Rep. 2023; 20(4):308-319.
PMID: 37402108
PMC: 10421789.
DOI: 10.1007/s11897-023-00613-1.
Non-alcoholic fatty liver disease across endocrinopathies: Interaction with sex hormones.
Arefhosseini S, Ebrahimi-Mameghani M, Najafipour F, Tutunchi H
Front Endocrinol (Lausanne). 2022; 13:1032361.
PMID: 36419770
PMC: 9676462.
DOI: 10.3389/fendo.2022.1032361.
Accuracy of Noninvasive Diagnostic Tests for the Detection of Significant and Advanced Fibrosis Stages in Nonalcoholic Fatty Liver Disease: A Systematic Literature Review of the US Studies.
Gosalia D, Ratziu V, Stanicic F, Vukicevic D, Zah V, Gunn N
Diagnostics (Basel). 2022; 12(11).
PMID: 36359453
PMC: 9689671.
DOI: 10.3390/diagnostics12112608.
Long-Term Adverse Effect of Liver Stiffness on Glycaemic Control in Type 2 Diabetic Patients with Nonalcoholic Fatty Liver Disease: A Pilot Study.
Mantovani A, Taverna A, Cappelli D, Beatrice G, Csermely A, Sani E
Int J Mol Sci. 2022; 23(20).
PMID: 36293337
PMC: 9604384.
DOI: 10.3390/ijms232012481.
Quantitative Prediction of Steatosis in Patients with Non-Alcoholic Fatty Liver by Means of Hepatic MicroRNAs Present in Serum and Correlating with Hepatic Fat.
Quintas G, Caiment F, Rienda I, Perez-Rojas J, Pareja E, Castell J
Int J Mol Sci. 2022; 23(16).
PMID: 36012565
PMC: 9408888.
DOI: 10.3390/ijms23169298.
Association between lower plasma adiponectin levels and higher liver stiffness in type 2 diabetic individuals with nonalcoholic fatty liver disease: an observational cross-sectional study.
Mantovani A, Zusi C, Csermely A, Salvagno G, Colecchia A, Lippi G
Hormones (Athens). 2022; 21(3):477-486.
PMID: 35831700
PMC: 9464740.
DOI: 10.1007/s42000-022-00387-6.
Non-Invasive Diagnostic Test for Advanced Fibrosis in Adolescents With Non-Alcoholic Fatty Liver Disease.
Mosca A, Della Volpe L, Alisi A, Veraldi S, Francalanci P, Maggiore G
Front Pediatr. 2022; 10:885576.
PMID: 35558366
PMC: 9086671.
DOI: 10.3389/fped.2022.885576.
Interaction of , and Increases Susceptibility to Nonalcoholic Steatohepatitis.
Xu K, Zheng K, Zhu P, Liu W, Ma H, Li G
J Clin Transl Hepatol. 2022; 10(2):219-229.
PMID: 35528982
PMC: 9039704.
DOI: 10.14218/JCTH.2021.00067.
